Edesa Biotech Inc (EDSA) Stock Analysis

Edesa Biotech Inc (EDSA) is a publicly traded company in the HEALTHCARE sector. It trades at $6.83, carries a market capitalization of $59.49M. This page summarizes the public market data, fundamentals, and frequently asked questions for EDSA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.83
• Market Cap: $59.49M
• EPS: $-1.31
• 52-Week High: $20.32
• 52-Week Low: $0.72

Market Sentiment

Edesa Biotech Inc currently has a Neutral sentiment score of 0.09.

About Edesa Biotech Inc

Edesa Biotech Inc. (EDSA), a clinical-stage biopharmaceutical company based in Markham, Canada, is dedicated to developing innovative therapies targeting inflammatory and immune-related diseases. With a strong focus on unmet medical needs, Edesa's pipeline features proprietary technologies aimed at advancing treatment options for dermatological and gastrointestinal disorders. As the company progresses through its clinical trials, it is poised to establish a significant presence in the biother...

GNG Research Analysis

GNG Research scores Edesa Biotech Inc (EDSA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EDSA.

Frequently Asked Questions

Does EDSA pay dividends?

Edesa Biotech Inc (EDSA) does not currently pay a regular dividend.

What is EDSA's market cap?

Edesa Biotech Inc (EDSA) has a market capitalization of $59.49M with a current stock price of $6.83.